Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
lactis B420 is a trademarked probiotic strain with published human trial data
Industry Analysis Published: December 22, 2025 Content Category: Dietary Supplements - Weight Management Regulatory Framework: DSHEA supplement regulations, FTC endorsement guidelines, FDA dietary supplement guidance Target Market: New Year 2026 Weight Loss Season
The April 2024 Phase 3 readout in type 2 diabetes reported a 14.2% mean body-weight reduction at 68 weeks for CagriSema 2.4mg/2.4mg versus 10.2% for semaglutide 2.4mg alone [4]
Improve your experience by using Chrome, Edge, Safari or Firefox
US$ 20.73
US$ 24.12
US$ 28.44
US$ 24.98
US$ 28.49
US$ 22.27
US$ 28.29
US$ 21.65
US$ 22.22
US$ 26.78
US$ 24.50
US$ 26.52
